Dow Chemical announced Tuesday that its joint venture
membrane chlor-alkali facility with Tokyo, Japan-based Mitsui
& Co. has successfully initiated full-scale, commercial
production in Freeport, Texas.
Dows share of the chlorine produced at the Freeport
facility will serve the growing feedstock
needs of its
performance- and market-driven businesses. In addition, Dow
will market the caustic soda on behalf of the joint venture.
This world-class facility allows us to capitalize on
our modern and efficient membrane chlor-alkali technology
and serves as a
real-life proof point of how new, competitive energy
resources in the U.S. are re-shaping the landscape of US Gulf
Coast manufacturing, said James (Jim) R. Fitterling,
Dow executive vice president.
This joint venture bolsters the integration
strength of the
chlorine value chain at the Freeport site in a capital
efficient model that allows Dow to invest in more downstream
businesses with higher and more consistent earnings.
The new facility has a name plate capacity of approximately
800,000 tpy of chlorine. As previously announced in December
2013, this new world-scale facility will replace 800,000 tpy
of older capacity on the site, according to company